The Impact of Regulatory Policies on the Future of Fecal Microbiota Transplantation

Keyphrases

• Approved Drugs 50%
• Clostridium Difficile Infection 50%
• Drug Approval 50%
• Fecal Microbiota Transplantation 100%
• Gut Microbiota 50%
• Market Exclusivity 50%
• New Drug Application 50%
• Off-label Use 50%
• Patient Innovation 50%
• Patient-centered Research 50%
• Potential Impact 100%
• Regulatory Decisions 50%
• Regulatory Options 50%
• Regulatory Policy 100%
• Selling 50%
• Stool 50%
• Stool Bank 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Clostridium Difficile Infection 50%
• Drug Approval 50%
• Feces microflora 100%
• Intestine Flora 50%
• Off-Label Use 50%

Medicine and Dentistry

• Clostridium Difficile Infection 50%
• Fecal Microbiota Transplantation 100%
• Gut Microbiota 50%
• Off-Label Use 50%